Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study

Melina Arnold(Centre international de recherche sur le cancer), Mark J. Rutherford(University of Leicester), Aude Bardot(Centre international de recherche sur le cancer), Jacques Ferlay(Centre international de recherche sur le cancer), Therése Andersson(Karolinska Institutet), Tor Åge Myklebust(Ålesund Hospital), Hanna Tervonen(Cancer Institute of New South Wales), Vicky Thursfield(Cancer Council Victoria), David Ransom(Government of Western Australia Department of Health), Lorraine Shack(Alberta Health Services), Ryan Woods, Donna Turner(CancerCare Manitoba), Suzanne Leonfellner(Government of New Brunswick), Susan Ryan(Dr. H. Bliss Murphy Cancer Centre), Nathalie Saint‐Jacques(Nova Scotia Health Authority), Prithwish De(Cancer Care Ontario), Carol McClure, Agnihotram V. Ramanakumar(McGill University Health Centre), H. Stuart-Panko(Saskatchewan Cancer Agency), Gerda Engholm(Danish Cancer Society), Paul M. Walsh(National Cancer Registry), Christopher Jackson(Cancer Society of New Zealand), Sally Vernon(Public Health England), Eileen Morgan(Queen's University Belfast), Anna Gavin(Queen's University Belfast), David Morrison(National Health Service Scotland), Dyfed Huws(Public Health Wales), Geoff Porter(Canadian Partnership Against Cancer), John Butler(Royal Marsden Hospital), Heather Bryant(Canadian Partnership Against Cancer), David C. Currow(Cancer Institute of New South Wales), Sara Hiom(Cancer Research Horizons), D. Max Parkin(University of Oxford), Peter Sasieni(King's College London), Paul C. Lambert(University of Leicester), Bjørn Møller(Cancer Registry of Norway), Isabelle Soerjomataram(Centre international de recherche sur le cancer), Freddie Bray(Centre international de recherche sur le cancer)
The Lancet Oncology
September 11, 2019
Cited by 1,040Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis